BNP Paribas Financial Markets’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54.5K | Sell |
11,191
-9,883
| -47% | -$48.1K | ﹤0.01% | 3418 |
|
2025
Q1 | $78K | Sell |
21,074
-23,043
| -52% | -$85.3K | ﹤0.01% | 3301 |
|
2024
Q4 | $176K | Buy |
+44,117
| New | +$176K | ﹤0.01% | 3103 |
|
2022
Q4 | – | Sell |
-206
| Closed | -$1.44K | – | 3819 |
|
2022
Q3 | $1.44K | Sell |
206
-502
| -71% | -$3.51K | ﹤0.01% | 3670 |
|
2022
Q2 | $6.53K | Buy |
708
+170
| +32% | +$1.57K | ﹤0.01% | 3155 |
|
2022
Q1 | $9.69K | Sell |
538
-1,056
| -66% | -$19K | ﹤0.01% | 3234 |
|
2021
Q4 | $41.8K | Buy |
1,594
+600
| +60% | +$15.7K | ﹤0.01% | 3125 |
|
2021
Q3 | $35.6K | Buy |
994
+561
| +130% | +$20.1K | ﹤0.01% | 2986 |
|
2021
Q2 | $23.8K | Sell |
433
-290
| -40% | -$15.9K | ﹤0.01% | 2891 |
|
2021
Q1 | $59.9K | Buy |
723
+329
| +84% | +$27.3K | ﹤0.01% | 2987 |
|
2020
Q4 | $44.8K | Sell |
394
-40
| -9% | -$4.55K | ﹤0.01% | 2953 |
|
2020
Q3 | $13.2K | Buy |
434
+262
| +152% | +$7.98K | ﹤0.01% | 3296 |
|
2020
Q2 | $7.55K | Sell |
172
-227
| -57% | -$9.97K | ﹤0.01% | 3204 |
|
2020
Q1 | $14.3K | Buy |
399
+252
| +171% | +$9.03K | ﹤0.01% | 3360 |
|
2019
Q4 | $9.79K | Buy |
147
+7
| +5% | +$466 | ﹤0.01% | 3458 |
|
2019
Q3 | $21.7K | Buy |
140
+50
| +56% | +$7.74K | ﹤0.01% | 3277 |
|
2019
Q2 | $7.75K | Sell |
90
-79
| -47% | -$6.8K | ﹤0.01% | 3534 |
|
2019
Q1 | $23.3K | Buy |
+169
| New | +$23.3K | ﹤0.01% | 3266 |
|
2018
Q4 | – | Sell |
-19
| Closed | -$13.5K | – | 3703 |
|
2018
Q3 | $13.5K | Hold |
19
| – | – | ﹤0.01% | 2940 |
|
2018
Q2 | $10.2K | Sell |
19
-94
| -83% | -$50.6K | ﹤0.01% | 3122 |
|
2018
Q1 | $12.7K | Buy |
+113
| New | +$12.7K | ﹤0.01% | 3405 |
|